The glucagon-like peptide (GLP)-1 receptor (GLP-1R) is a class BG protein–coupled
receptor (GPCR) that mediates the action of GLP-1, a peptide hormone secreted from three …

Glucagon-like peptide 1 (GLP-1) is a 30-amino acid peptide hormone produced in the
intestinal epithelial endocrine L-cells by differential processing of proglucagon, the gene …

We examined the effect of intravenously infused glucagon-like peptide 1 (GLP-1) on
subjective appetite sensations after an energy-fixed breakfast, and on spontaneous energy …

Maintaining the high standards that made the previous editions such well-respected and
widely used references, Food Lipids: Chemistry, Nutrition, and Biotechnology, Fourth Edition …

Despite dramatic fluctuations in calorie intake, animals maintain a very stable body weight.
The reason is that energy intake and expenditure are precisely matched. Long-term …

Fructose consumption and its implications on public health are currently under study. This
work reviewed the metabolic fate of dietary fructose based on isotope tracer studies in …

OBJECTIVE: Peripheral infusions of glucagon-like peptide-1 (GLP-1) in humans have been
shown to inhibit gastrointestinal motility and decrease hunger and energy intake. However …

This study tested the hypothesis that the amount (weight or volume) of food consumed
affects the satiating potency of a food, independent of its energy content. Normal-weight …

NN2211 is a long-acting, metabolically stable glucagon-like peptide-1 (GLP-1) derivative
designed for once daily administration in humans. NN2211 dose dependently reduced the …

Ingestion of food simultaneously activates gastrointes-tinal motility, gastric and pancreatic
secretion, and release of gastrointestinal hormones that, in turn, modulate motor, secretory …